VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_13-vv-00395
Package ID: USCOURTS-cofc-1_13-vv-00395
Petitioner: Katelin B. Krause
Filed: 2013-06-13
Decided: 2020-04-20
Vaccine: HPV
Vaccination date: 
Condition: transverse myelitis
Outcome: compensated
Award amount USD: 50000

AI-assisted case summary:
Katelin B. Krause, formerly Katelin Arnold, filed a petition on June 13, 2013, alleging that she developed transverse myelitis after receiving human papillomavirus (HPV), hepatitis A, hepatitis B, and influenza vaccinations. The respondent denied that these vaccinations caused the petitioner's injury. After several years of litigation, the parties filed a joint stipulation on March 24, 2020, agreeing to settle the case. Special Master Mindy Michaels Roth reviewed the stipulation and found it reasonable, adopting it as the decision of the Court. As part of the settlement, the respondent agreed to issue a lump sum payment of $50,000.00, payable to Katelin Krause, as compensation for all damages available under 42 U.S.C. § 300aa-15(a). The public decision does not describe the petitioner's specific clinical story, onset of symptoms, diagnostic tests, treatments, or the specific mechanism of causation. Petitioner was represented by Robert Krakow, Esq., of the Law Office of Robert J. Krakow, and respondent was represented by Debra Begley, Esq., of the US Department of Justice.

Theory of causation field:
Petitioner alleged that HPV, Hepatitis A, Hepatitis B, and Influenza vaccines caused her to develop transverse myelitis. The parties reached a joint stipulation on March 24, 2020, to settle the case. Special Master Mindy Michaels Roth adopted the stipulation. Petitioner was awarded $50,000.00 as a lump sum. Petitioner was represented by Robert Krakow, Esq., and respondent by Debra Begley, Esq. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_13-vv-00395-1
Date issued/filed: 2020-04-20
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 3/24/2020) regarding 108 DECISION Stipulation/Proffer. Signed by Special Master Mindy Michaels Roth. (mw) Service on parties made.
--------------------------------------------------------------------------------
Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 13-395V
Filed: March 24, 2020
* * * * * * * * * * * * *
KATELIN B. KRAUSE, * UNPUBLISHED
*
Petitioner, * Decision on Joint Stipulation;
* Transverse Myelitis (“TM”);
v. * Human papillomavirus
* (“HPV”) Vaccine; Hepatitis A
SECRETARY OF HEALTH * Vaccine; Hepatitis B Vaccine;
AND HUMAN SERVICES, * Influenza (“Flu”) Vaccine
*
Respondent. *
* * * * * * * * * * * * *
Robert Krakow, Esq., Law Office of Robert J. Krakow, New York, NY, for petitioner.
Debra Begley, Esq., US Department of Justice, Washington, DC, for respondent.
DECISION ON JOINT STIPULATION1
Roth, Special Master:
On June 13, 2013, Katelin Krause2 [“Ms. Krause” or “petitioner”] filed a petition for
compensation under the National Vaccine Injury Compensation Program.3 Petitioner alleges that
she developed transverse myelitis (“TM”) after receiving human papillomavirus (“HPV”),
hepatitis A, hepatitis B, and influenza vaccinations. Stipulation, filed Mar. 24, 2020, at ¶¶ 1-4.
Respondent denies that any of the aforementioned immunizations caused petitioner’s injury.
Stipulation at ¶ 6.
1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the
Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-
347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision
will be available to anyone with access to the internet. However, the parties may object to the Decision’s
inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party
has fourteen days within which to request redaction “of any information furnished by that party: (1) that is
a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes
medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of
privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id.
2 Petitioner’s claim was initially filed under the name Katelin Arnold. On January 30, 2017, the case caption
was amended to reflect petitioner’s married name, Katelin B. Krause.
3 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease
of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa
(2012).

Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 2 of 7
Nevertheless, the parties have agreed to settle the case. On March 24, 2020, the parties
filed a joint stipulation agreeing to settle this case and describing the settlement terms.
Respondent agrees to issue the following payment:
A lump sum of $50,000.00 in the form of a check payable to petitioner, Katelin
Krause. This amount represents compensation for all damages that would be available
under § 300aa-15(a).
I adopt the parties’ stipulation attached hereto, and award compensation in the amount and
on the terms set forth therein. The clerk of the court is directed to enter judgment in accordance
with this decision.4
IT IS SO ORDERED.
s/ Mindy Michaels Roth
Mindy Michaels Roth
Special Master
4 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by each party filing a notice
renouncing the right to seek review.
2

Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 3 of 7

Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 4 of 7

Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 5 of 7

Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 6 of 7

Case 1:13-vv-00395-UNJ Document 109 Filed 04/20/20 Page 7 of 7